Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfenex Inc (NYSE MKT LLC:PFNX)

4.83
Delayed Data
As of Jun 22
 -0.17 / -3.40%
Today’s Change
3.91
Today|||52-Week Range
11.35
-46.75%
Year-to-Date
No recent news for Pfenex Inc.

Today’s Trading

Previous close5.00
Today’s open5.05
Day’s range4.81 - 5.10
Volume137,883
Average volume (3 months)101,735
Market cap$117.3M
Dividend yield--
Data as of 06/22/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,000.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+528.13%
P/E ratio32.2
Price/Sales3.57
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
CBMGCellular Biomedicine...+0.10+1.22%
--Wang On Group Ltd+0.00+16.67%
COOLPolarityte Inc+3.61+17.66%
AXSMAxsome Therapeutics ...+0.15+2.86%
Data as of 06/22/2017

Financials

Next reporting dateSeptember 1, 2017
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$60.2M
Annual profit (last year)$5.5M
Net profit margin9.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Secretary
Patrick K. Lucy
Chief Manufacturing &
Operations Officer
Steven S. Sandoval
Corporate headquarters
San Diego, California

Forecasts